These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 7102094)
41. Evaluating health outcomes in a clinic environment. Burnhill MS Int J Fertil Womens Med; 1997; 42(2):85-93. PubMed ID: 9160218 [No Abstract] [Full Text] [Related]
42. Modern concept and use of oral contraceptives. Chaudhuri SK J Indian Med Assoc; 1986 Apr; 84(4):124-6. PubMed ID: 3772128 [No Abstract] [Full Text] [Related]
43. Oral contraceptives and venous thromboembolism. Paul C N Z Med J; 1997 Feb; 110(1037):41. PubMed ID: 9066568 [No Abstract] [Full Text] [Related]
44. [Incidence distribution of the so-called risk factors among ovulation inhibitors]. Ravens KG; Doré G; Jipp P Verh Dtsch Ges Inn Med; 1975; 81():1725-7. PubMed ID: 1227069 [No Abstract] [Full Text] [Related]
45. Benefits and risk of oral contraceptives. A reassessment. Burkman RT J Reprod Med; 1991 Mar; 36(3 Suppl):217-8. PubMed ID: 2046074 [No Abstract] [Full Text] [Related]
46. A new generation of oral contraceptives. What you need to know. Gallagher R; Fuller CA Adv Nurse Pract; 1997 Nov; 5(11):38-40, 80. PubMed ID: 9460000 [No Abstract] [Full Text] [Related]
47. OCs--update on usage, safety, and side effects. Popul Rep A; 1979 Jan; (5):A133-86. PubMed ID: 759243 [No Abstract] [Full Text] [Related]
48. New warnings on the way for oral contraceptives. Zimmerly JG J Leg Med (N Y); 1977 Feb; 5(2):23-4. PubMed ID: 299872 [No Abstract] [Full Text] [Related]
49. [Mortality caused by cardiovascular diseases in Denmark before and after the introduction of the pill]. Lidegaard O Ugeskr Laeger; 1984 Dec; 147(1):39-40. PubMed ID: 6523623 [No Abstract] [Full Text] [Related]
51. [Recommendations of the Swiss Society for Family Planning concerning ovulation inhibitors]. Hauser GA; Mall-Haefeli M Ther Umsch; 1970 Oct; 27(10):631-3. PubMed ID: 5512719 [No Abstract] [Full Text] [Related]
52. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population. Morin-Papunen L; Martikainen H; McCarthy MI; Franks S; Sovio U; Hartikainen AL; Ruokonen A; Leinonen M; Laitinen J; Järvelin MR; Pouta A Am J Obstet Gynecol; 2008 Nov; 199(5):529.e1-529.e10. PubMed ID: 18533124 [TBL] [Abstract][Full Text] [Related]
53. Oral contraceptives for women over the age of 35. Mishell DR Int J Fertil; 1991; 36 Suppl 2():55-60; discussion 60-4. PubMed ID: 1679419 [No Abstract] [Full Text] [Related]
54. Controversies in family planning: are all oral contraceptive formulations created equal? Sober SP; Schreiber CA Contraception; 2011 May; 83(5):394-6. PubMed ID: 21477679 [No Abstract] [Full Text] [Related]
55. [Should oral contraceptives be discontinued before surgery or during illness?]. Abildgaard U; Fagerhol MK Tidsskr Nor Laegeforen; 1971 Mar; 91(9):667. PubMed ID: 5576185 [No Abstract] [Full Text] [Related]
56. Risks of oral contraceptive use in women over 35. Stenchever MA J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860 [TBL] [Abstract][Full Text] [Related]
58. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs. Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738 [TBL] [Abstract][Full Text] [Related]
59. Oral contraceptives: where are the excess deaths? Vessey MP; Mann JI Med J Aust; 1981 Oct; 2(8):390. PubMed ID: 7321967 [TBL] [Abstract][Full Text] [Related]
60. Fertility control for women after 35. Hatcher RA; Adams JB Urban Health; 1977 Apr; 6(3):19, 33, 52. PubMed ID: 10235883 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]